Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
This article describes the trajectory of adherence patterns among users of sodium-glucose cotransporter 2 (SGLT2) inhibitors. The authors found that baseline factors were unable to predict the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results